Abstract:Objective: To observe the clinical effect of dorsal root ganglion pulse radio frequency combined with interferon in the treatment of postherpetic neuralgia. Methods: A total of 78 patients with postherpetic neuralgia in our department from March 2022 to June 2023 were selected and divided into interferon group (group A) and control group (group B). The two groups were treated with dorsal root ganglion pulse radio frequency therapy under the guidance of CT. In group A, recombinant human interferon α-2b (IFN α-2b) was added to the drug formula injected along the puncture needle after radio frequency. In group B, the other drugs were the same as those in group A except that IFN α-2b was not added to the drug formula. Visual analogue scale (VAS) score and pittsburgh sleep quality index (PSQI) score were performed at 1, 2, 4 and 12 time points before treatment and after treatment. The degree of pain relief was evaluated at 12 weeks after treatment. Infrared thermal imaging of the skin of the lesion site was taken before treatment and 1 and 4 weeks after treatment, and the temperature difference between the lesion site and the normal skin site was analyzed. Results: Compared with before treatment, VAS score and PSQI score of both groups were decreased at each time point after treatment, and the score of group A was significantly lower than that of group B (P<0.05). At 1 and 4 weeks after treatment, the temperature difference between the affected side and the healthy side became smaller, and the temperature difference in group A was lower than that in group B (P<0.05). The pain relief rate of group A was higher than that of group B (P<0.05). None of the patients had serious adverse reactions. Conclusion: The efficacy of dorsal root ganglion pulse radio frequency combined with interferon in the treatment of postherpetic neuralgia is better than that of dorsal root ganglion pulse radio frequency alone, and there is no serious adverse reaction.